Lima Bruna G A, Silva Renata Raianny, Meira Hugo M, Durval Italo J B, Macedo Bezerra Filho Clovis, Silva Thayse A L, Sarubbo Leonie A, Luna Juliana Moura
Postgraduate Program in Development of Environmental Processes, Catholic University of Pernambuco (UNICAP), Príncipe Street, n. 526-Boa Vista, Recife 50050-900, Brazil.
Northeast Biotechnology Network (RENORBIO), Federal Rural University of Pernambuco, Dom Manuel de Medeiros Street, Dois Irmãos, Recife 52171-900, Brazil.
Microorganisms. 2024 Sep 6;12(9):1849. doi: 10.3390/microorganisms12091849.
Surfactants can be used as nanoparticle stabilizing agents. However, since synthetic surfactants are not economically viable and environmentally friendly, biosurfactants are emerging as a green alternative for the synthesis and stabilization of nanoparticles. Nanoparticles have been applied in several areas of industry, such as the production of biomedical and therapeutic components, packaging coating, solar energy generation and transmission and distribution of electrical energy, among others. The aim of this study was to synthesize, in a simple and green way, silver nanoparticles (AgNPs) using the biosurfactant produced by UCP 0899 as a stabilizer. AgNPs were examined and morphologically characterized using the techniques of ultraviolet-visible spectroscopy (UV-visible), scanning electron microscopy (SEM), zeta potential and energy dispersive X-ray spectroscopy (EDS). Newly formed silver nanoparticles showed a maximum UV-visible absorption peak at 400 nm, while a shift to 410 nm was observed in those stored for 120 days. SEM micrograph confirmed the formation of nanoparticles with an average size of 20 nm and with a predominant spherical structure, while a zeta potential of -60 mV suggested that the use of the biosurfactant promoted their stability. Stabilized nanoparticles were tested for their antimicrobial activity against bacterial isolates of , , and sp., as well as fungal isolates of and . At a concentration of 16.50 µg/mL, AgNPs inhibited the growth of all target microorganisms according to the following decreasing order: (95%), , (90%), (85%), sp. (75%) and (71%). These results suggest the potential use of the biosurfactant as a stabilizer of silver nanoparticles as an antimicrobial agent in different industrial sectors. Furthermore, the in vivo toxicity potential of biosurfactants was evaluated using the model. The larvae were treated with concentrations in the range of 2.5, 5.0 and 10 g/L, and no mortality was observed within the 24 to 72 h period, demonstrating non-toxicity within the tested concentration range. These findings support the safety, efficacy and non-toxicity of biosurfactant-stabilized nanoparticles.
表面活性剂可用作纳米颗粒稳定剂。然而,由于合成表面活性剂在经济上不可行且不环保,生物表面活性剂正作为一种绿色替代品,用于纳米颗粒的合成与稳定。纳米颗粒已应用于多个工业领域,如生物医学和治疗成分的生产、包装涂层、太阳能发电以及电能的传输与分配等。本研究的目的是以简单且绿色的方式,使用UCP 0899产生的生物表面活性剂作为稳定剂来合成银纳米颗粒(AgNPs)。利用紫外可见光谱(UV-visible)、扫描电子显微镜(SEM)、zeta电位和能量色散X射线光谱(EDS)技术对AgNPs进行了检测和形态表征。新形成的银纳米颗粒在400 nm处显示出最大紫外可见吸收峰,而储存120天的颗粒则观察到吸收峰移至410 nm。SEM显微照片证实形成了平均尺寸为20 nm且主要为球形结构的纳米颗粒,而-60 mV的zeta电位表明生物表面活性剂的使用促进了它们的稳定性。对稳定化的纳米颗粒针对金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌和枯草芽孢杆菌属的细菌分离株以及白色念珠菌和热带念珠菌的真菌分离株进行了抗菌活性测试。在浓度为16.50 µg/mL时,AgNPs按照以下递减顺序抑制了所有目标微生物的生长:金黄色葡萄球菌(95%)、大肠杆菌、铜绿假单胞菌(90%)、枯草芽孢杆菌属(85%)、白色念珠菌(75%)和热带念珠菌(71%)。这些结果表明生物表面活性剂作为银纳米颗粒稳定剂在不同工业领域作为抗菌剂的潜在用途。此外,使用秀丽隐杆线虫模型评估了生物表面活性剂的体内潜在毒性。用2.5、5.0和10 g/L范围内的浓度处理幼虫,在24至72小时内未观察到死亡,表明在测试浓度范围内无毒。这些发现支持了生物表面活性剂稳定化纳米颗粒具有安全性、有效性和无毒性。